Related topics:
Fda Panel stories:
FDA panel backs stronger benefits of Spiriva
Nov 19th, 2009 - Times Online
Federal health experts say an inhaler drug from a German drugmaker works well enough to carry bolder claims about reducing coughing, wheezing and other respiratory problems.
FDA panel backs safety, benefits of Spiriva
Nov 19th, 2009 - Forbes
WASHINGTON -- Federal health experts on Thursday brushed off lingering safety questions about a popular inhaler drug and suggested it carry bolder benefit claims. The...
US panel backs Pfizer's newer Prevnar vaccine
Nov 18th, 2009 - Reuters
* FDA panel: Pfizer's Prevnar 13 safe, effective * FDA decision due by late December * Pfizer shares gain 1.4 pct (Recasts; Adds panel member quotes) BETHESDA, Md., Nov 18 (Reuters) - Pfizer Inc (PFE.
FDA panel backs Pfizer's enhanced vaccine for kids
Nov 18th, 2009 - Houston Chronicle
BETHESDA, Md. — Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers...FDA Panel to Consider New Flu Vaccine Technology
Nov 13th, 2009 - Wall Street Journal
WASHINGTON -- A federal advisory panel will meet next week to consider a new type of influenza vaccine that's made without relying on decades-old technology that employs millions of chicken eggs to grow viruses used for flu shots.



